Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-10 of 10
Keywords: Tamoxifen
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2012) 35 (7-8): 451–453.
Published Online: 03 July 2012
... at this time. The patient was treated with leuprolide 11.25 mg every 3 months and tamoxifen 20 mg twice daily. The patient’s inhibin B level began to decrease after 1 month and returned to normal after 4 months. The patient has been maintained on this treatment for 2 years and has tolerated the drugs well...
Journal Articles
Subject Area:
Oncology
Bernd Metzner, Jochen Casper, Gernot Hartung, Bernd Rosien, Erhard Hölzle, Peter Pelzer, Claus-Henning Köhne
Journal:
Onkologie
Onkologie (2011) 34 (4): 208–209.
Published Online: 18 March 2011
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tamoxifen Melanoma Maintenance therapy Long-term follow-up Metastatic disease Letter...
Journal Articles
Subject Area:
Oncology
Michael P. Lux, Achim Wöckel, Agnes Benedict, Stefan Buchholz, Noé;mi Kreif, Nadia Harbeck, Rolf Kreienberg, Manfred Kaufmann, Matthias W. Beckmann, Walter Jonat, Peyman Hadji, Wolfgang Distler, Guenther Raab, Hans Tesch, Georg Weyers, Kurt Possinger, Andreas Schneeweiss
Journal:
Onkologie
Onkologie (2010) 33 (4): 155–166.
Published Online: 19 March 2010
...: In the ‘Arimidex’, Tamoxifen Alone or in Combination (ATAC) trial, the aromatase inhibitor (AI) anastrozole had a significantly better efficacy and safety profile than tamoxifen as initial adjuvant therapy for hormone receptor-positive (HR+) early breast cancer (EBC) in postmenopausal patients. To compare...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1996) 19 (5): 430–434.
Published Online: 12 May 2009
...K. Böhning; M. Busch; M. Rave-Fränk; E. Dühmke Background: Due to the increasingly common use of endocrine therapy in adjuvant and palliative therapy of breast cancer, a significant number of patients will be treated with radiation therapy and Tamoxifen (TMX) at the same time. Methods: MCF-7 breast...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1994) 17 (4): 376–380.
Published Online: 11 May 2009
... surgical procedureí lave to be accepted. Recent data concerning the mode of action of hormonal treatment indicate the presence of oestrogen receptors in about one third of the tumours. Casuistic contributions reported on 22 patients treated with tamoxifen, of whom 9 (41%) responded to therapy. Experience...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1994) 17 (Suppl. 1): 49–53.
Published Online: 11 May 2009
...G.P. Breitbach; C. Reister; H. Droege; G. Bastert Mit dem Ziel einer pharmakokinetischen Vergleichsanalyse zwischen Tamoxifen (T) und dem neuen Antiöstrogen Droloxifen (D) wurden seit 1985 28 Patientinnen mit metastasierenden Mammakarzinomen zu gleichen Teilen doppelblind randomisiert mit jeweils...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1994) 17 (Suppl. 1): 6–16.
Published Online: 11 May 2009
...E. Dahme; B. Rattel Die chronische Toxizität von Droloxifen (DROL) und Tamoxifen (TAM) wurde in zwei Studien untersucht. In der ersten wurden Gruppen von je 25 Ratten pro Geschlecht 26 Wochen lang täglich mit 0,2,20 und 200 mg/kg DROL in 0,25% Agar-suspension mittels Magenschlundsonde behandelt...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1993) 16 (5): 297–303.
Published Online: 08 May 2009
...P. Götzinger; M. Gnant; E. Hochstöger; R. Jakesz Incidence of breast cancer is increasing. Although modifications in breast cancer therapy were achieved, the mortality rate remained unchanged. 21 years ago, tamoxifen was used for the first time in the treatment of advanced breast cancer of post...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1984) 7 (Suppl. 2): 66–73.
Published Online: 22 April 2009
... Patienten, die allerdings von einer Zytostatika-Testung profitieren können, scheint weit unter 10% zu liegen. Anhand von eigenen Untersuchungen wird der Einfluß von verschiedenen Hormonen und Antiöstrogenen auf die Koloniebildung beim Ovarialkarzinom dargestellt. Tamoxifen und sein Metabolit 4-Hydroxy...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1982) 5 (Suppl. 1): 35–39.
Published Online: 21 April 2009
...B. Maßner; I. Voß; W. Queißer; P. Drings; D. Fritze; M. Westerhausen Auf der Suche nach einer alternativen Therapie bei Patientinnen mit zytostatisch ausbehandeltem Mammakarzinom setzten wir Tamoxifen, Vindesin und Carmustin (BCNU) ein. 27 Patientinnen wurden in eine Studie aufgenommen, die eine...